外周动脉疾病患者种族差异的区域变异
基于血管质量倡议2003至2017年15个去标识区域数据,纳入90418例接受腹股沟下血运重建或截肢的白人或黑人患者,黑人15527例(17%)。调整后30天死亡率、主要不良肢体事件和截肢率在不同区域间变异明显,围手术期种族差异存在区域变异,但长期结局的种族差异无显著区域变异。
要点
- 黑人患者更年轻,糖尿病、肢体威胁性缺血、透析依赖和高血压比例更高(均P<.05)。
- 调整后30天死亡率白人1.2%至2.1%、黑人0%至3.0%,截肢率白人0.3%至1.2%、黑人0%至2.1%。
- 长期黑人较白人死亡率更低(HR 0.80)、主要不良肢体事件更高(HR 1.15)、截肢更高(HR 1.33)。
核心结论
- 外周动脉疾病患者下肢手术后存在显著种族差异,区域变异参与围手术期但不参与长期结局差异。
- 作者认为表现不佳的区域应利用这些数据开展质量改进项目,理解差异病因对改善所有外周动脉疾病患者照护至关重要。
研究设计与样本
- 回顾性分析血管质量倡议2003至2017年15个去标识区域中接受腹股沟下血运重建或截肢的白人或黑人患者。
- 排除手术量<100例的区域,最终纳入90418例患者,其中黑人15527例(17%)。
- 患者接受旁路手术31263例、血管内介入52462例、截肢6693例。
主要发现
- 黑人患者更年轻,吸烟、冠心病、慢性阻塞性肺疾病比例更低,糖尿病、肢体威胁性缺血、透析依赖、高血压及自费或医疗补助比例更高(均P<.05)。
- 调整后30天死亡率白人1.2%至2.1%、黑人0%至3.0%,主要不良肢体事件白人4.0%至8.3%、黑人2.4%至8.1%,截肢率白人0.3%至1.2%、黑人0%至2.1%。
- 多个区域黑人调整后30天死亡率和截肢率与白人显著不同(有高有低,P<.05),主要不良肢体事件无显著差异。
- 各区域内种族组间所有结局的调整率均存在显著区域变异(均P<.01)。
- 调整分析中黑人较白人长期死亡率更低(HR 0.80,95%CI 0.73-0.88,P<.001),主要不良肢体事件更高(HR 1.15,95%CI 1.06-1.25,P<.001),截肢更高(HR 1.33,95%CI 1.18-1.51,P<.001),无显著区域变异。
临床怎么用
- 作者认为表现不佳的区域应利用这些数据开展质量改进项目。
- 作者认为理解这些差异的病因对改善所有外周动脉疾病患者的照护至关重要。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Prior studies identified significant racial disparities as well as regional variation in outcomes of patients with peripheral artery disease (PAD). We aimed to determine whether regional variation contributes to these racial disparities. METHODS: We identified all white or black patients who underwent infrainguinal revascularization or amputation in 15 deidentified regions of the Vascular Quality Initiative between 2003 and 2017. We excluded three regions with <100 procedures. We used multivariable linear regression, allowing clustering at the hospital level to calculate the marginal effects of race and region on adjusted 30-day mortality, major adverse limb events (MALEs), and amputation. We compared long-term outcomes between black and white patients within each region and within patients of each race treated in different regions using multivariable Cox regression. RESULTS: We identified 90,418 patients, 15,527 (17%) of whom were black. Patients underwent 31,263 bypasses, 52,462 endovascular interventions, and 6693 amputations. Black patients were younger and less likely to smoke, to have coronary artery disease, or to have chronic obstructive pulmonary disease, but they were more likely to have diabetes, limb-threatening ischemia, dialysis dependence, and hypertension and to be self-insured or on Medicaid (all P < .05). Adjusted 30-day mortality ranged from 1.2% to 2.1% across regions for white patients and 0% to 3.0% for black patients; adjusted 30-day MALE varied from 4.0% to 8.3% for white patients and 2.4% to 8.1% for black patients; and adjusted 30-day amputation rates varied from 0.3% to 1.2% for white patients and 0% to 2.1% for black patients. Black patients experienced significantly different (both higher and lower) adjusted rates of 30-day mortality and amputation than white patients did in several regions (P < .05) but not MALEs. In addition, within each racial group, we found significant variation in the adjusted rates of all outcomes between regions (all P < .01). In adjusted analyses, compared with white patients, black patients experienced consistently lower long-term mortality (hazard ratio [HR], 0.80; 95% confidence interval [CI], 0.73-0.88; P < .001) and higher rates of MALEs (HR, 1.15; 95% CI, 1.06-1.25; P < .001) and amputation (HR, 1.33; 95% CI, 1.18-1.51; P < .001), with no statistically significant variation across the regions. However, rates of all long-term outcomes varied within both racial groups across regions. CONCLUSIONS: Significant racial disparities exist in outcomes after lower extremity procedures in patients with PAD, with regional variation contributing to perioperative but not long-term outcome disparities. Underperforming regions should use these data to generate quality improvement projects, as understanding the etiology of these disparities is critical to improving the care of all patients with PAD.
引用
- O'Donnell TFX, Powell C, Deery SE, et al. Regional variation in racial disparities among patients with peripheral artery disease. J Vasc Surg. 2018. PMID: 29459014. doi:10.1016/j.jvs.2017.10.090
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。